BioCentury | Nov 25, 2020
Management Tracks

DBV CSO stepping down; plus moves at Idera, Ultimovacs, Omniome, Humacyte and Aelis Farma

...and strategic planning, will retire at year-end and remain a consultant to the company.Immunotherapy company Ultimovacs...
...and development at H. Lundbeck A/S (CSE:LUN) before retiring in 2018. Danielle Golovin DBV Technologies S.A. Idera Pharmaceuticals Inc. Ultimovacs A/S Genenta...
BioCentury | Jan 26, 2015
Financial News

Ultimovacs completes venture financing

Ultimovacs A/S , Oslo, Norway Business: Cancer Date completed: 2015-01-22 Type: Venture financing Raised: NOK45 million ($5.9 million) Investors: Canica; Sundt WIR Staff...
BioCentury | May 13, 2013
Emerging Company Profile

Ultimovacs: hTERT redux

...a cancer vaccine, hoping to elicit a better immune response than that seen with GV1001, Ultimovacs...
...more potent than the peptide used in GV1001, said Gaudernack. The resulting vaccine, UV1, is Ultimovacs'...
...Oslo, Norway Ultimovacs AS , Oslo, Norway University of Genoa , Genoa, Italy Sidebars Ultimovacs...
Items per page:
1 - 3 of 3
BioCentury | Nov 25, 2020
Management Tracks

DBV CSO stepping down; plus moves at Idera, Ultimovacs, Omniome, Humacyte and Aelis Farma

...and strategic planning, will retire at year-end and remain a consultant to the company.Immunotherapy company Ultimovacs...
...and development at H. Lundbeck A/S (CSE:LUN) before retiring in 2018. Danielle Golovin DBV Technologies S.A. Idera Pharmaceuticals Inc. Ultimovacs A/S Genenta...
BioCentury | Jan 26, 2015
Financial News

Ultimovacs completes venture financing

Ultimovacs A/S , Oslo, Norway Business: Cancer Date completed: 2015-01-22 Type: Venture financing Raised: NOK45 million ($5.9 million) Investors: Canica; Sundt WIR Staff...
BioCentury | May 13, 2013
Emerging Company Profile

Ultimovacs: hTERT redux

...a cancer vaccine, hoping to elicit a better immune response than that seen with GV1001, Ultimovacs...
...more potent than the peptide used in GV1001, said Gaudernack. The resulting vaccine, UV1, is Ultimovacs'...
...Oslo, Norway Ultimovacs AS , Oslo, Norway University of Genoa , Genoa, Italy Sidebars Ultimovacs...
Items per page:
1 - 3 of 3